Open Access Articles- Top Results for Dopexamine


Systematic (IUPAC) name
Clinical data
AHFS/ International Drug Names
86197-47-9 7pxY
PubChem CID 55483
ChemSpider 50102 7pxY
UNII 398E7Z7JB5 7pxY
KEGG D03891 7pxY
Chemical data
Formula C22H32N2O2
429.43 g/mol
 14pxY (what is this?)  (verify)

Dopexamine is a synthetic analogue of dopamine. Despite this, it is a β1 and β2-adrenergic receptor agonist.[1] Its action at dopamine receptor D1 mediates relaxation of vascular smooth muscle in renal, mesenteric, cerebral and coronary arteries. Mild action at D2 receptors decreases noradrenaline release.[2]

Use in sepsis has been proposed.[3]

It is used as an inotropic agent in cardiac failure.[4] Side effects include arrhythmia, tremor, angina and flushing.


  1. ^ Perrin G, Papazian L, Martin C. (1993). "Dopexamine: a new dopaminergic agonist". Ann Fr Anesth Reanim. 12 (3): 308–320. PMID 7902685. 
  2. ^ Brown RA, Dixon J, Farmer JB et al. (July 1985). "Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors". Br. J. Pharmacol. 85 (3): 599–608. PMC 1916510. PMID 2862944. doi:10.1111/j.1476-5381.1985.tb10554.x. 
  3. ^ Birnbaum J, Klotz E, Spies CD et al. (2006). "Effects of dopexamine on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats". Crit Care 10 (4): R117. PMC 1750974. PMID 16893450. doi:10.1186/cc5011. 
  4. ^ Lisbon A (May 2003). "Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence?". Chest 123 (5 Suppl): 460S–3S. PMID 12740229. doi:10.1378/chest.123.5_suppl.460S. 

Lua error in package.lua at line 80: module 'Module:Buffer' not found.